A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension

Journal of Cardiovascular Translational Research

Volumn 9, Issue 2, 2016, Pages 162-164

  Mohamed, Nura A ^a,b,c   Ahmetaj Shala, Blerina ^a   Duluc, Lucie ^b   Mackenzie, Louise S ^d   Kirkby, Nicholas S ^a   Reed, Daniel M ^a   Lickiss, Paul D ^b   Davies, Robert P ^b   Freeman, Gemma R ^b   Wojciak Stothard, Beata ^b   Chester, Adrian H ^b   El Sherbiny, Ibrahim M ^e   Mitchell, Jane A ^a   Yacoub, Magdi H ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Qatar Foundation Research and Development Division   (Qatar)

^d UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^e Center for Materials Science   (Egypt)

Author keywords

Aorta; Endothelial cells; Nanomedicine; Nanoparticles; Nitric oxide; NO releasing nanoparticles; Pulmonary arterial hypertension; Pulmonary artery; Pulmonary artery vascular smooth muscle cells

Indexed keywords

NANOPARTICLE; NITRIC OXIDE; ANTIHYPERTENSIVE AGENT; NITRIC OXIDE DONOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENDOTHELIUM CELL; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SUSTAINED RELEASE FORMULATION; ANIMAL; ARTERIAL PRESSURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG FORMULATION; HYPERTENSION, PULMONARY; KINETICS; METABOLISM; NANOMEDICINE; PATHOPHYSIOLOGY; PULMONARY ARTERY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; HYPERTENSION, PULMONARY; KINETICS; MICE; NANOMEDICINE; NANOPARTICLES; NITRIC OXIDE; NITRIC OXIDE DONORS; PULMONARY ARTERY;

EID: 84960124312     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-016-9684-2     Document Type: Article

References (5)

1. Ghofrani, H. A., & Humbert, M. (2014). The role of combination therapy in managing pulmonary arterial hypertension. European Respiratory Review, 23(134), 469–475.
2. Archer, S. L., Weir, E. K., & Wilkins, M. R. (2010). Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation, 121(18), 2045–2066.
3. Tonelli, A. R., Haserodt, S., Aytekin, M., & Dweik, R. A. (2013). Nitric oxide deficiency in pulmonary hypertension: pathobiology and implications for therapy. Pulmonary Circulation, 3(1), 20–30.
4. Barst, R. J., Channick, R., Ivy, D., & Goldstein, B. (2012). Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulmonary Circulation, 2(2), 139–147.
5. El-Sherbiny, I. M., El-Baz, N. M., & Yacoub, M. H. (2015). Inhaled nano- and microparticles for drug delivery. Global Cardiology Science & Practice, 2015, 2.